chron's disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Crohn's disease involves an inappropriate immune response where the body's immune system attacks the gastrointestinal tract, causing inflammation. This is due to an imbalance between pro-inflammatory and anti-inflammatory signals in the gut.

• Secondary mechanism: The inflammation leads to the thickening of the intestinal wall and formation of deep ulcers, which can disrupt normal digestive processes and cause symptoms like abdominal pain and diarrhea.

• Key complication: Chronic inflammation can result in scar tissue formation (fibrosis), leading to bowel obstruction or strictures, which may require medical intervention or surgery.

Patient Profile

Demographics:

28-year-old female, office administrator

History:

• Key past medical history: Diagnosed with Crohn's disease 2 years ago, no previous surgeries

• Current medications: Mesalamine 2.4 g/day, multivitamin daily

• Allergies: None known

Current Presentation:

• Chief complaint: Mild abdominal pain and occasional diarrhea

• Key symptoms: Abdominal cramping, bloating, and intermittent diarrhea, no weight loss or fever

• Vital signs: Blood pressure 118/76 mmHg, heart rate 72 bpm, respiratory rate 16 breaths/min, temperature 98.6°F, BMI 22.3

Section 1

Initial assessment findings:

Upon initial assessment, the patient presents with a stable condition and reports a manageable level of discomfort. Her abdominal pain is rated as 3 on a scale of 1 to 10, with 10 being the most severe. The pain is localized to the lower right quadrant, consistent with her history of Crohn's disease. On physical examination, there is mild tenderness noted in the same area, but no palpable masses or rigidity. Bowel sounds are present and active, indicating ongoing gastrointestinal activity despite the inflammation. The patient denies any nausea or vomiting, and her appetite remains unchanged.

Laboratory tests reveal slightly elevated C-reactive protein (CRP) levels at 12 mg/L (normal <10 mg/L), suggesting mild inflammation consistent with her Crohn's disease. Her complete blood count (CBC) shows a normal white blood cell count with no signs of anemia, indicating that her current inflammation is not causing systemic effects. Liver function tests and electrolyte levels are within normal limits, confirming no immediate metabolic or hepatic complications.

The patient's current medication regimen of Mesalamine appears to be effective in managing her symptoms, although the mild abdominal pain and occasional diarrhea suggest a need for ongoing monitoring and possibly an adjustment in therapy. The initial assessment highlights the importance of regular follow-up and symptom tracking to prevent potential progression to more severe complications, such as strictures or bowel obstructions, which could alter her treatment plan. A diet review and stress management plan may also be beneficial to optimize her overall health and symptom control.

Section 2

Following the initial assessment, the healthcare team decides to conduct further diagnostic testing to ensure comprehensive management of the patient's Crohn's disease. An abdominal ultrasound is performed to assess the intestines for any signs of complications such as thickening of the bowel wall or fistulas, which are common in Crohn's disease. The ultrasound reveals slight thickening of the terminal ileum but no evidence of fistulas or abscesses, aligning with her stable condition and suggesting mild disease activity.

In addition to the ultrasound, a fecal calprotectin test is conducted to evaluate intestinal inflammation more closely. The results show a moderately elevated level of 150 µg/g (normal <50 µg/g), which further confirms the presence of mild inflammation. This finding, in conjunction with her slightly elevated CRP levels, supports the decision to continue her current medication regimen while considering minor adjustments to optimize symptom control.

The healthcare team discusses the importance of dietary management with the patient, emphasizing a diet low in inflammatory foods and high in soluble fibers to aid digestion. They also recommend implementing a stress management plan, including techniques such as mindfulness and gentle exercise, to minimize any potential triggers for her symptoms. The patient is advised to maintain regular follow-up appointments for monitoring and to promptly report any changes in symptoms, particularly increased pain or changes in bowel patterns, to prevent progression to more severe complications. This approach ensures that her condition remains stable and manageable, providing a foundation for continued quality of life.

Section 3

Several weeks after implementing the new dietary and stress management recommendations, as well as continuing her medication regimen, the patient returns for a follow-up appointment. During the visit, she reports feeling more energetic and experiencing fewer abdominal cramps. She has adhered to the advised low-inflammatory diet and has integrated daily mindfulness exercises and light yoga into her routine, which she finds both calming and manageable.

The nurse conducts a comprehensive assessment, noting that the patient's vital signs are stable: blood pressure is 120/80 mmHg, heart rate is 72 bpm, respiratory rate is 16 breaths per minute, and her temperature is normal at 98.6°F (37°C). She reports having one to two bowel movements per day, which are more formed and less frequent than before. Her weight has remained stable, indicating that nutritional status is well-maintained. Laboratory results show a slight decrease in CRP to 8 mg/L (previously 10 mg/L), suggesting a mild reduction in systemic inflammation. Her repeat fecal calprotectin test shows a level of 120 µg/g, indicating slight improvement in gastrointestinal inflammation.

The healthcare team is pleased with these positive indicators and discusses with the patient the importance of continued adherence to her management plan. They reinforce the value of ongoing monitoring and encourage her to maintain regular check-ins with her healthcare providers. The patient is reminded to stay vigilant for any new symptoms or changes in her condition, particularly as Crohn's disease can be unpredictable. They agree on scheduling the next follow-up in three months, unless new symptoms necessitate an earlier evaluation. This plan aims to sustain her current stability and prevent disease progression, ensuring she continues to enjoy a good quality of life.

Section 4

Several weeks later, the patient returns for her scheduled follow-up appointment. During this visit, she reports experiencing a slight increase in fatigue and intermittent joint pain, particularly in the mornings. While her abdominal cramps remain infrequent, she mentions that she occasionally feels bloated after meals. Despite these new symptoms, she continues to adhere to her dietary and lifestyle modifications and maintains her medication regimen.

The nurse conducts a thorough assessment, noting that the patient’s vital signs remain stable with a blood pressure of 118/78 mmHg, heart rate of 70 bpm, respiratory rate of 16 breaths per minute, and a temperature of 98.4°F (36.9°C). However, a physical examination reveals mild tenderness in the lower right quadrant of the abdomen and slight swelling in the joints of her fingers. The patient's weight has stayed consistent, suggesting her nutritional status is still adequate.

Considering the new symptoms and physical findings, the healthcare team decides to order additional diagnostic tests to further evaluate the patient's condition. They request a complete blood count (CBC) to check for anemia or increased inflammation markers, and an erythrocyte sedimentation rate (ESR) to assess for any systemic inflammation. The team discusses the potential for these symptoms to be related to Crohn's disease-associated arthritis, a common extra-intestinal manifestation. They emphasize the importance of continued observation and stress the need for the patient to report any worsening of symptoms promptly. This approach aims to address her current discomfort while preventing any potential complications from developing.

Section 5

A week later, the patient returns to the clinic for a review of her test results. The nurse informs her that the complete blood count (CBC) showed a slight decrease in hemoglobin levels, suggesting mild anemia, and the erythrocyte sedimentation rate (ESR) was moderately elevated, indicating some systemic inflammation. These findings align with the possibility of Crohn's disease-associated arthritis contributing to her joint pain and fatigue. Despite these results, the patient’s vital signs remain stable with a blood pressure of 120/80 mmHg, heart rate of 72 bpm, respiratory rate of 16 breaths per minute, and a temperature of 98.2°F (36.8°C).

The healthcare team decides to adjust the patient’s treatment plan to address her anemia and joint discomfort. They recommend starting an iron supplement to help improve her hemoglobin levels and suggest introducing a low-impact exercise regimen to maintain joint mobility and reduce stiffness. Additionally, they discuss the use of non-steroidal anti-inflammatory drugs (NSAIDs) cautiously, considering her gastrointestinal condition. The team advises the patient to monitor her symptoms closely, particularly any changes in bowel habits or increased pain, and to maintain her current dietary and medication regimen.

The patient expresses understanding of the new recommendations and feels reassured by the proactive approach of the healthcare team. She is encouraged to keep a symptom diary to track any changes and help in identifying potential triggers. The nurse emphasizes the importance of follow-up appointments to monitor her response to the new interventions and to ensure that her condition remains stable. This plan aims to manage her current symptoms effectively while preventing further complications, fostering a sense of control and confidence in managing her Crohn's disease.